Expression Pathology has established important relationships with a range of different companies and institutions. Our collaborators include tissue providers, mass spectrometry analysis laboratories, leading academic institutions and instrument developers, as well as bioinformatics companies.
Expression Pathology Inc. is a leader in tissue proteomics.
Using our tissue analysis
platform we are developing targeted tissue proteomic assays for oncology.
The tests will provide information to guide treatment decisions – the
presence of protein drug targets, or which biological pathways are
activated in tumors to aid prognosis and drug selection.
Our scientists have extensive experience in pathology,
proteomics and tissue analysis. Call us to discuss your project. We can
help you design your experiment, and we can also help you with grant
writing.
The patented Liquid Tissue® MS protocol prepares FFPE
samples for mass spec analysis. Complete solubilization
captures the entire protein content. Mass spec friendly.
Requires only 30,000 cells for multiple
mass spectrometry analyses.
The Director® Laser Microdissection Slides
provide the fastest, easiest and most accurate way
to collect specific cellular features from tissue sections. Engineered
for use with existing
Leica LMD and PALM Zeiss laser microdissection system.
Investors
We are seeking investments and collaboration opportunities.
For more information please contact our business development group.
b u s d e v @ e x p r e s s i o n p a t h o l o g y . c o m
Transcribe email address to standard format. Spam bots have made it impossible to post properly formatted
email addresses.
